Clinical Trials in Denver

Showing 17941-17960 of 18,161 trials

Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

NCT00066885

This Phase 1/2 clinical trial is a multi-center, open-label study with three main objectives. The first (Phase 1A) is to determine the maximum-tolerated dose of DN-101 when administered in combination with Taxotere (docetaxel) every three weeks (closed). The second is to determine the maximum-tolerated dose of DN-101 when administered weekly in combination with Taxotere(docetaxel)devery three weeks (open). The third is to evaluate the safety and objective tumor response rate of the combination in NSCLC. DN-101 doses will be escalated at three dosing levels. Patients will receive oral DN-101 on day one, followed by intravenous docetaxel on day two of a 21-day cycle. Treatment cycles will be repeated at the same dose level each 21 days until disease progression or unacceptable toxicity.

Carcinoma, Non-Small-Cell Lung

Novacea80 participantsStarted Jun 2003

Berkeley, California, United States • Vallejo, California, United States • Denver, Colorado, United States +8 more locations

COMPLETEDNA< 1 mile

Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

NCT00012558

A long-term study of current treatments for bipolar disorder, including medications and psychosocial therapies.

Bipolar Disorder

National Institute of Mental Health (NIMH)5,000 participantsStarted Sep 1998

Stanford, California, United States • Denver, Colorado, United States • Boston, Massachusetts, United States +8 more locations

Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

Find Trials by Condition in Denver

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment

Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

US Inhaled Insulin Therapeutic Choice Questionnaire Study

Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects

Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer

Buprenorphine and Integrated HIV Care Evaluation

UT-15C SR in the Treatment of Critical Limb Ischemia

Sleep Quality in CHIMES (MF101)

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

De-Medicalizing Mifepristone Medical Abortion

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease

RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia